After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CADL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Candel Therapeutics Inc is $288.09M. A total of 0.99 million shares were traded on the day, compared to an average of 991.31K shares.
In the most recent transaction, Nichols William Garrett sold 45,316 shares of CADL for 8.76 per share on Mar 18 ’25. After the transaction, the Chief Medical Officer now owns 52,493 company shares. In a previous transaction on Mar 18 ’25, Barone Francesca sold 32,146 shares at 8.76 per share. CADL shares that Chief Scientific Officer owns now total 96,527.
Among the insiders who sold shares, Tak Paul Peter disposed of 25,772 shares on Mar 18 ’25 at a per-share price of $8.77. This resulted in the Chief Executive Officer holding 226,140 shares of CADL after the transaction. In another insider transaction, Tak Paul Peter sold 400 shares at $9.00 per share on Mar 19 ’25. Company shares held by the Chief Executive Officer now total 225,740.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CADL has a high of $14.60 and a low of $3.79.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CADL’s latest balance sheet shows that the firm has $82.64M in Cash & Short Term Investments as of fiscal 2021. There were $560.00k in debt and $5.36M in liabilities at the time. Its Book Value Per Share was $1.52, while its Total Shareholder’s Equity was $64.14M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CADL is Buy with a score of 5.00.
